| Market Today: Coinbase Surges Amid Bitcoin Rally, Gold Hits Record High Dec 01 / GuruFocus News - Paid Partner Content | Could Ozempic Harm These 3 Medical Device Stocks? Nov 25 / MotleyFool.com - Paid Partner Content |
| Will Novo Nordisk Be a Trillion-Dollar Stock by 2030? Dec 01 / MotleyFool.com - Paid Partner Content | Here's Why Investors Should Hold Encompass Health (EHC) Now Nov 24 / Zacks.com - Paid Partner Content |
| FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug Nov 30 / Zacks.com - Paid Partner Content | Top Stock Reports for Eli Lilly, Accenture & The TJX Companies Nov 24 / Zacks.com - Paid Partner Content |
| Is it a Good Idea to Invest in Harpoon (HARP) Stock Now? Nov 30 / Zacks.com - Paid Partner Content | Novo Nordisk (NVO) to Expand Manufacturing Site in France Nov 24 / Zacks.com - Paid Partner Content |
| Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy? Nov 30 / MotleyFool.com - Paid Partner Content | Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More Nov 24 / Zacks.com - Paid Partner Content |
| Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd Nov 29 / GuruFocus News - Paid Partner Content | New Strong Buy Stocks for November 24th Nov 24 / Zacks.com - Paid Partner Content |
| Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine Nov 29 / Zacks.com - Paid Partner Content | $3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years Nov 23 / MotleyFool.com - Paid Partner Content |
| Is Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year? Nov 29 / Zacks.com - Paid Partner Content | Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why Nov 23 / Zacks.com - Paid Partner Content |
| Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study Nov 29 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies Nov 22 / Zacks.com - Paid Partner Content |
| Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock? Nov 29 / MotleyFool.com - Paid Partner Content | Merck (MRK) to Acquire Private Neuroscience Company for $610M Nov 22 / Zacks.com - Paid Partner Content |
| AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag Nov 28 / Zacks.com - Paid Partner Content | Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago Nov 22 / Zacks.com - Paid Partner Content |
| 3 Large Drug Stocks That Have Outperformed Industry YTD Nov 28 / Zacks.com - Paid Partner Content | Top Analyst Reports for Novo Nordisk, Bank of America & Netflix Nov 21 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights Gartner, The Progressive, InterContinental Hotels, Cboe Global Markets and Novo Nordisk Nov 28 / Zacks.com - Paid Partner Content | J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant Nov 21 / Zacks.com - Paid Partner Content |
| 5 Must-Buy Stocks at 52-Week High With More Upside for 2024 Nov 27 / Zacks.com - Paid Partner Content | Is Novo Nordisk (NVO) a Buy as Wall Street Analysts Look Optimistic? Nov 21 / Zacks.com - Paid Partner Content |
| Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus Nov 27 / Zacks.com - Paid Partner Content | Lilly (LLY) to Build $2.5B Plant to Meet Increased Drug Demand Nov 20 / Zacks.com - Paid Partner Content |
| 4 Must-Buy Profitable Stocks Using Net Income Ratio Nov 27 / Zacks.com - Paid Partner Content | Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. Nov 20 / MotleyFool.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce Nov 27 / Zacks.com - Paid Partner Content | 3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist Nov 20 / MotleyFool.com - Paid Partner Content |
| Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout? Nov 26 / MotleyFool.com - Paid Partner Content | Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock? Nov 19 / MotleyFool.com - Paid Partner Content |
-1.45 / -1.42%